Table 17 The cost-effectiveness analysis in the 12-month intervention period (the incidence of diabetes)
Group | C (yuan) | E (%) | C/E | ΔC/ΔE |
|---|---|---|---|---|
The treatment group | 22967057.6 | 16.5 | 1391942.9 | −204989.1 |
The control group | 20425193.3 | 28.9 | 706754.1 |
Group | C (yuan) | E (%) | C/E | ΔC/ΔE |
|---|---|---|---|---|
The treatment group | 22967057.6 | 16.5 | 1391942.9 | −204989.1 |
The control group | 20425193.3 | 28.9 | 706754.1 |
Trials